Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia

This publication has 27 references indexed in Scilit:

• Anticoagulation with Novastan^®(Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
  Seminars in Thrombosis and Hemostasis, 1997
• Heparin induced thrombocytopenia
  European Journal of Vascular and Endovascular Surgery, 1996
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995
• Annotation
  British Journal of Haematology, 1995
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
  Journal of Clinical Investigation, 1994
• Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition
  The Annals of Thoracic Surgery, 1992
• Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolism
  American Heart Journal, 1992
• Immune Endothelial-Cell Injury in Heparin-Associated Thrombocytopenia
  New England Journal of Medicine, 1987
• Heparin-lnduced Thrombocytopenia, Thrombosis, and Hemorrhage
  Annals of Surgery, 1983
• Heparin-Associated Thrombocytopenia
  New England Journal of Medicine, 1980